cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Aurinia Pharmaceuticals Inc
40 own
63 watching
Current Price
$8.99
$-0.11
(-1.21%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,277.57M
52-Week High
52-Week High
20.4752
52-Week Low
52-Week Low
4.07
Average Volume
Average Volume
2.47M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,277.57M
icon52-Week High20.4752
icon52-Week Low4.07
iconAverage Volume2.47M
iconDividend Yield--
iconP/E Ratio--
What does the Aurinia Pharmaceuticals Inc do?
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.
Read More
How much money does Aurinia Pharmaceuticals Inc make?
News & Events about Aurinia Pharmaceuticals Inc.
Business Wire
14days ago
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia) announces that the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office has terminated the Inter Partes Review (IPR) it had instituted with respect to Aurinias U.S. Patent No. 10,286,036. About LUPKYNIS LUPKYNIS...
PR Newswire
14days ago
Thinking about buying stock in First Wave BioPharma, GasLog Partners, Canoo, Aurinia Pharmaceuticals, or Rocket Lab USA? Thinking about buying stock in First Wave BioPharma, GasLog Partners, Canoo, Aurinia Pharmaceuticals, or Rocket Lab USA? PR Newswire NEW YORK, Jan. 25, 2023 NEW YORK, Jan. 25...
Ticker Report
25days ago
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH Get Rating) (TSX:AUP) has been assigned a consensus rating of Moderate Buy from the six analysts that are presently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating...
Business Wire
1month ago
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today provided an update on its business performance. Preliminary unaudited net revenue for the three months and full year ended December 31, 2022 was approximately $28.4 million and $134.0 million. For the three months ended...
Business Wire
1month ago
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) announces it has entered into a settlement agreement with Sun Pharmaceutical Industries, Inc., Sun Pharmaceuticals Industries, Ltd., and Sun Pharma Global FZE (collectively, Sun Pharmaceuticals) that involves both Aurinia and Sun...
Frequently Asked Questions
Frequently Asked Questions
What is Aurinia Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Aurinia Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Aurinia Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Aurinia Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Aurinia Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Aurinia Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Aurinia Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Aurinia Pharmaceuticals Inc?
plus_minus_icon
What percentage is Aurinia Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Aurinia Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$8.99
$-0.11
(-1.21%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00